Verified Bulk Drugs & APIs
manufacturers & suppliers in India
India is a major manufacturer and exporter of bulk drugs & apis, with production concentrated in Ahmedabad, Vadodara, Mumbai, and exported about $360 million of bulk drugs & apis in FY25-26 (HS 3003). diipl connects global and domestic buyers with verified Indian bulk drugs & apis manufacturers, and generates verified export buyers for Indian bulk drugs & apis makers. Every supplier and buyer is verified before you meet, never a raw data list.
Buyers and sourcing teams also search for these makers as api manufacturers, bulk drug manufacturers, active pharmaceutical ingredient manufacturers.
manufacturer / exporter
domestic buyer
India supplies only a small slice of a world market that runs into billions, so the room to grow is real. diipl shows Indian makers exactly where their product fits and generates the verified buyers to capture it, and gives buyers a verified, meeting-ready Indian supplier, matched to their requirement.
HSN code and HS code for bulk drugs & apis
Bulk Drugs & APIs is classified under HS heading 3003 (medicaments(excluding goods of heading 3002,3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale). The exact 6-digit subheading depends on the material, construction and specification of what you make, and the 8-digit ITC-HS line is what India actually files.
In India the GST HSN code and the export ITC-HS code are the same nomenclature, so this line is the one your GST invoice and your shipping bill share. The classification is shown here; the applicable GST rate is not.
Chapter
30
Pharmaceuticals
Heading (4)
3003
Product group
Subheading (6)
Varies
International, same worldwide
ITC-HS (8)
India files this
Confirmed in your report
Subheadings under HS 3003
Which one applies depends on your exact specification. Picking the wrong line changes the duty your buyer pays and the incentive you can claim.
- 300310 — Medicaments; containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale)
- 300320 — Medicaments; containing antibiotics other than penicillins, streptomycins and their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale)
- 300331 — Medicaments; containing insulin, for therapeutic or prophylactic uses, not packaged for retail sale
- 300339 — Medicaments; containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale
- 300341 — Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale)
- 300342 — Medicaments; containing alkaloids or their derivatives, containing pseudoephedrine (INN) or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale)
- 300343 — Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale)
- 300349 — Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts; for therapeutic or prophylactic uses, (not packaged for retail sale)
A classification is a fact any lookup can give you. Heading 3003 sits in chapter 30 (pharmaceuticals), and the subheading that actually applies to your bulk drugs & apis depends on material, construction and specification. Getting that choice right changes the duty your buyer pays. But the correct code still does not tell you which countries are buying bulk drugs & apis right now, what duty each of them charges on the Indian line, or whether that demand has grown or faded. Those answers come from trade data, not from a code table, and they are what decides whether a market is worth entering at all. diipl's free Market Research Report answers them for your specific product.
The 6-digit line is international. India requires the 8-digit ITC-HS for both import and export. Look up every 8-digit line under 3003 free, with whether India actually exported on it, in the HS code finder. What a code table cannot tell you is where the product sells.
Where does your bulk drugs & apis fit in the global market?
Bulk pharmaceutical compounds built on Indian APIs move from Hyderabad, Ahmedabad, Vadodara and Mumbai into regulated and semi-regulated markets worldwide, with tariffs at or near zero everywhere. Japan's PMDA sets the highest bar globally but rewards suppliers with a long sales cycle and strong lifetime value once qualified. USFDA audit track-record and CEP or COS filing are what open doors in the West. diipl connects proven Indian bulk-drug manufacturers with the buyers already running that qualification process. diipl pinpoints the high-demand, low-tariff markets where you can win, generates the verified buyers there, and secures your compliance as you scale to the world.
Import duty on bulk drugs & apis by market
The standard (MFN) duty importers pay. Where India has a trade agreement, your price gets a further edge, revealed in your report.
- United States0% MFNno FTA
- United Kingdom0% MFNCETA · duty-free
- UAE0% MFNCEPA · duty-free
- Germany0% MFNno FTA
- Japan0% MFNCEPA · duty-free
Duty rates: ITC. Preferential (FTA/CEPA) rates are revealed in your free report.
The markets that decide your strategy
Your free report reveals who pays India the most, where growth is steady, and where demand is emerging, so you target the markets you can actually win.
Who pays India the most
The markets buying the most from India today.
- Top market$ ••• M+ •• %
- Top market$ ••• M+ •• %
- Top market$ ••• M+ •• %
- Top market$ ••• M+ •• %
- Top market$ ••• M+ •• %
Where growth is consistent
Steady, rising year-on-year demand, not one-off spikes.
- Top market$ ••• M+ •• %
- Top market$ ••• M+ •• %
- Top market$ ••• M+ •• %
- Top market$ ••• M+ •• %
Where demand is emerging
The fastest-growing import markets worldwide.
- Top market$ ••• M+ •• %
- Top market$ ••• M+ •• %
- Top market$ ••• M+ •• %
- Top market$ ••• M+ •• %
- Top market$ ••• M+ •• %
Your bulk drugs & apis export growth strategy, built for you
diipl pinpoints the top high-demand, low-tariff markets where you can win, generates the verified buyers there, and secures your NTM compliance as you build exports to the world. Free, delivered by a diipl research analyst.
Primary Indian manufacturing clusters: Ahmedabad, Vadodara, Mumbai.
How diipl generates your buyers
A managed, research-led service. We do the work; you meet buyers who are ready.
Research top markets
We identify the destination markets with real, steady demand for your product and a genuine competitive position for Indian supply.
Omni-channel outreach
Targeted outreach across LinkedIn, Google, Meta, email and WhatsApp reaches importers who are actively sourcing, not cold lists.
Verify every buyer
Each buyer is qualified on budget, authority, need and timeline before it ever reaches you. A verified buyer, not a raw enquiry.
Meeting
We set a scheduled meeting with the verified buyer, matched to your capacity. You show up to a conversation that is ready to move.
Frequently asked questions
What is the HS code for bulk drugs & apis?
Bulk Drugs & APIs is classified under HS heading 3003 (medicaments(excluding goods of heading 3002,3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale). The exact 6-digit subheading depends on the material, construction and specification, and India files an 8-digit ITC-HS line on the shipping bill. You can look up every 8-digit line free, and whether India actually exported on it, in the diipl HS code finder.
What is the difference between the 6-digit HS code and the 8-digit ITC-HS code?
The first 6 digits are the international Harmonized System subheading, the same in every member country. India extends it to 8 digits as the ITC-HS line, and that is what appears on your shipping bill. The 8-digit line decides the duty your buyer pays, whether an FTA preferential rate and certificate of origin apply, your RoDTEP or drawback rate, and whether an export licence is required. Indian ITC-HS lines are re-notified periodically, so a code that was correct last year may no longer be active.
Who makes bulk drugs & apis in India?
India's main bulk drugs & apis manufacturing clusters are Ahmedabad, Vadodara, Mumbai. diipl works with verified Indian bulk drugs & apis manufacturers (also searched as api manufacturers), each verified on budget, authority, need and timeline, and matches buyers to the right maker for their specification.
Which countries are the largest importers of Indian bulk drugs & apis?
India exported about $360 million of bulk drugs & apis (HS 3003) in FY25-26. Which countries buy the most of it, where demand is growing most consistently, and which markets are only now opening up all shift year to year, and they differ by grade and specification, so a generic top-ten list is rarely the answer for a specific factory. diipl researches that ranking for your product and walks you through it market by market in a free Market Research Report, alongside the import duty you would pay in each one.
Who are the leading api manufacturers in India?
diipl connects buyers with verified api manufacturers in India. For Bulk Drugs & APIs (HS 3003), every supplier is verified on budget, authority, need and timeline before you meet. Sourcing? Share your requirement and we introduce a matched, verified manufacturer. Manufacturing bulk drugs & apis? We generate verified export buyers for your factory.
Which Indian cities are bulk drugs & apis manufacturing hubs?
Major Indian bulk drugs & apis manufacturing clusters include Ahmedabad, Vadodara, Mumbai. diipl works with verified manufacturers across these hubs and matches you to the right one for your requirement.
What is the import duty on bulk drugs & apis in major markets?
The standard (MFN) import duty on bulk drugs & apis (HS 3003) is 0% in United States, 0% in United Kingdom, 0% in UAE, 0% in Germany, 0% in Japan. Where India has a trade agreement (such as CEPA or CETA), the preferential rate is lower, revealed in your free market research report.
Who imports bulk drugs & apis from India?
Indian bulk drugs & apis reach a wide set of import markets across the Gulf, Europe, North America and Asia. diipl identifies the importers actively sourcing your product, verifies each one on budget, authority, need and timeline, and shows you the exact markets and demand in your free market research report.
How do I find verified export buyers for bulk drugs & apis?
diipl runs the research on the export markets that want your product, then runs omni-channel outreach across LinkedIn, Google, Meta, email and WhatsApp, verifies every buyer, and sets a meeting matched to your capacity. You get verified export buyers, not a raw list.
What certifications do bulk drugs & apis buyers ask for?
Common requirements include USFDA, EU-GMP, WHO-GMP, CEP / COS. Exact requirements vary by destination market; diipl factors compliance into every buyer match so the meetings you take can actually transact.
How is this different from a buyer list or a marketplace?
A list or marketplace hands you unverified contacts to chase. diipl generates and verifies the buyer, then delivers a scheduled meeting. You meet a buyer with confirmed budget, authority, need and timeline, matched to what your factory can supply.